Glucagon Administration: A Checklist Guide for Safe Usage
Title: Glucagon Administration: A Checklist Guide for Safe Usage Abstract: Glucagon, a 29-amino acid peptide hormone, is critical for reversing severe hypoglycemia. Administration routes (IM, SC, IV, intranasal) vary by formulation; ready-to-use auto-injectors and nasal powder offer faster onset (≤10 min) versus traditional reconstitution kits. Market trends show a CAGR of 8.5% (2023–2030), driven by diabetes prevalence and biosimilar competition. Brand comparison: Baqsimi (intranasal) vs. GlucaGen (injectable) highlights trade-offs in stability (lyophilized vs. liquid) and ease-of-use. Regulatory compliance (FDA, EMA) and cold-chain logistics (2–8°C) are critical for potency. This checklist integrates pharmacokinetic data, device ergonomics, and storage protocols to ensure safe, effective administration.